PubMed COVID-19 Clinical Care
1871 - 1880 of 3558 results found
Incidence of type 1 diabetes in Chilean children between 2006 and 2021: significant increase during the COVID-19 pandemic
Description
CONCLUSIONS: T1D incidence rates in Chilean youth doubled between 2006 and 2018, subsequently presenting a striking increase during the COVID-19 pandemic.
Impact of Pharmacist-Led Education on Proper Prophylactic Enoxaparin Dosing in Obese Patients
Description
Background/Purpose: Venous thromboembolism (VTE) is a common cardiovascular complication in middle-aged adults. There is a likelihood a patient may experience VTE when admitted to a hospital. Prophylactic medications such as low-dose unfractionated
Impacts of COVID-19 Pandemic on Three IVF Clinics of Jakarta, Indonesia: A Retrospective Qualitative and Quantitative Study
Description
CONCLUSION: Those three clinics are prepared in facing COVID-19, as they complied with government regulations. As the COVID-19 pandemic progressed, the number of patients gradually returned to normal.
Impact of the COVID-19 pandemic on the changes in dietary habits, lifestyle and physical activity in the Slovak population
Description
CONCLUSIONS: The results show that the pandemic and the restrictions during it caused changes not only in diet, but also in physical activity, daily routine and overall lifestyle. However, this is a very specific issue that needs to be assessed in a
Intra-host variation in the spike S1/S2 region of a feline coronavirus type-1 in a cat with persistent infection
Description
Feline coronavirus type 1 (FCoV-1) is widely known for causing feline infectious peritonitis (FIP), a systemic infection that is often fatal, with the virus known as the FIPV biotype. However, subclinical disease also occurs, in which cats may not
Implementing Telemedicine During the COVID-19 Pandemic: Disparities in Utilization in an Urban Pain Medicine Practice
Description
CONCLUSION: We identified disparities in the utilization of telemedicine in Pain Medicine, which may be due to socioeconomic factors such as lack of access to reliable internet access, cost of devices, and technological know-how. This emphasizes the
Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial
Description
CONCLUSIONS: Sotrovimab 500-mg IM injection was well tolerated and noninferior to IV administration. IM administration could expand outpatient treatment access for COVID-19.
Independent prognostic value of the congestion and renal index in patients with acute heart failure
Description
CONCLUSIONS: In patients with AHF, CRI is independently associated with the risk of death or hospitalization within one year, and improves the risk stratification of the established risk models.